Clinical Trials

Showing trials with last updates posted in 2026.

NCT05945264 | NOT_YET_RECRUITING | NA
142 participants

Music Intervention for Preterm Birth

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2026-09-15
Completion:
2027-07-30
Conditions
  • Preterm Birth
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT05896839 | RECRUITING | PHASE1/PHASE2
16 participants

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-07-24
Completion:
2027-01-31
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
  • Metastatic Basal Cell Carcinoma
  • Metastatic Carcinoma in the Skin
  • Metastatic Melanoma
  • Metastatic Merkel Cell Carcinoma
  • Metastatic Skin Squamous Cell Carcinoma
  • Unresectable Basal Cell Carcinoma
  • Unresectable Melanoma
  • Unresectable Merkel Cell Carcinoma
  • Unresectable Skin Squamous Cell Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT05891171 | ACTIVE_NOT_RECRUITING | PHASE1
40 participants

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-10-13
Completion:
2027-09-30
Conditions
  • Advanced Cancer
  • Advanced Malignancies
  • Bladder Cancer
  • Cervical Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Gastroesophageal-junction Cancer (GEJ)
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Ovarian Cancer
  • Renal Cell Carcinoma (RCC)
  • Triple Negative Breast Cancer (TNBC)
Interventions
  • DRUG
No Results Yet
NCT05886036 | RECRUITING | PHASE2
70 participants

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-01-23
Completion:
2026-10-31
Conditions
  • Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05803382 | RECRUITING | PHASE1
30 participants

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-11-08
Completion:
2027-06-30
Conditions
  • Metastatic Colorectal Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Stage IV Colorectal Cancer AJCC v8
  • Unresectable Colorectal Carcinoma
  • Unresectable Malignant Solid Neoplasm
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05797246 | ACTIVE_NOT_RECRUITING | PHASE2
21 participants

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-08-02
Completion:
2027-07-31
Conditions
  • Respiratory Tract Diseases
  • Neoplasms
  • Neoplasms by Histologic Type
  • Neoplasms, Glandular and Epithelial
  • Neoplasms, Squamous Cell
  • Tumor Virus Infections
  • Infections
  • Virus Diseases
  • DNA Virus Infections
  • Pathologic Processes
  • Disease Attributes
  • Recurrence
  • Papilloma
  • Respiratory Tract Infections
  • Papillomavirus Infections
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page